1. Home
  2. Research
  3. Research Groups
  4. Psychiatric Diseases

Psychiatric Diseases

Search for publications

Only original articles, editorials, guidelines.

  • Llorca-Bofí V, Garriga M, Mezquida G, Garcia-Rizo C, Vieta E, Díaz-Caneja CM, Bernardo M, Madero S, Pina-Camacho L, Cuesta MJ, Bergé D, Baeza I, Bioque M, Amoretti S.

    Comparing PANSS-6 and PANSS-30 for clinical and functional outcomes in first-episode psychosis: A 2-year follow-up in a Spanish cohort.

    EUROPEAN NEUROPSYCHOPHARMACOLOGY . 95: 9-13.

    [doi:10.1016/j.euroneuro.2025.03.011]

  • Molero P, Ibañez A, de Diego-Adeliño J, Ramos-Quiroga JA, García Dorado M, López Rengel PM, Saiz PA.

    A Real-World Study on the Use, Effectiveness, and Safety of Esketamine Nasal Spray in Patients with Treatment-Resistant Depression: INTEGRATE Study.

    ADVANCES IN THERAPY . 42(5): 2335-2353.

    [doi:10.1007/s12325-025-03149-z]

  • Segura AG, Prohens L, Julià L, Amoretti S, RIbero M, Pino-Camacho L, Cano-Escalera G, Mane A, Rodriguez-Jimenez R, Roldan A, Sarró S, Ibañez A, Usall J, Lobo A, Garcia-Rizo C, Cuesta MJ, Parellada M, González-Pinto A, Berrocoso E, Bernardo M, Mas S, Rodríguez N, Perez-Ramos A, Salmeron S, González-Peñas J, Gurriarán X, Farré A, Pousa E, Zorrilla I, Mar-Barrutia L, Trabsa A, Martinez L, Sánchez-Cabezudo Á, Jiménez-López E, Pomarol-Clotet E, Salvador R, Butjosa A, Elena RA, Moreno-Izco L, Torres AMS, Saiz J, León-Quismondo L, Rivero O, González-Blanco L, De-la-Cámara C.

    Methylation profile scores of environmental exposures and risk of relapse after a first episode of schizophrenia.

    EUROPEAN NEUROPSYCHOPHARMACOLOGY . 94: 4-15.

    [doi:10.1016/j.euroneuro.2025.02.003]

  • Cardoner N, Gutiérrez-Rojas L, Saiz P, Lahera G, Álvarez-Mon MÁ, Alonso Ortega P, Pérez-Páramo M.

    Does pregabalin offer potential as a first-line therapy for generalized anxiety disorder? A meta-analysis of efficacy, safety, and cost-effectiveness.

    FRONTIERS IN PHARMACOLOGY . 16: 1483770-1483770.

    [doi:10.3389/fphar.2025.1483770]

  • Mas S, Julià L, Cuesta MJ, Crespo-Facorro B, Vázquez-Bourgon J, Spuch C, Gonzalez-Pinto A, Ibañez A, Usall J, Romero-López-Alberca C, Catalan A, Mané A, Bernardo M.

    Applied pharmacogenetics to predict response to treatment of first psychotic episode: study protocol.

    Frontiers in psychiatry . 15: 1497565-1497565.

    [doi:10.3389/fpsyt.2024.1497565]

  • Marín-Cavestany M, De la Cruz MÁ, Durán JI, Stiles BJ, Lahera G, Andrade-González N.

    Influence of Therapist Attachment Style on the Working Alliance in Individual Psychotherapy: A Systematic Review and Meta-Analysis.

    CLIN PSYCHOL PSYCHOT . 32(1): .

    [doi:10.1002/cpp.70025]

  • Ortega MA, Fraile-Martinez O, García-Montero C, Diaz-Pedrero R, Lopez-Gonzalez L, Monserrat J, Barrena-Blázquez S, Alvarez-Mon MA, Lahera G, Alvarez-Mon M.

    Understanding immune system dysfunction and its context in mood disorders: psychoneuroimmunoendocrinology and clinical interventions.

    Military Medical Research . 11(1): 80-80.

    [doi:10.1186/s40779-024-00577-w]

  • Fares-Otero NE, Verdolini N, Melero H, Andrés-Camazón P, Vilajosana E, Cavone V, García-Bueno B, Rapado-Castro M, Izquierdo A, Martín-Hernández D, Mola Cárdenes P, Leal I, Dompablo M, Ortiz-Tallo A, Martinez-Gras I, Muñoz-Sanjose A, Loeck de Lapuerta C, Rodriguez-Jimenez R, Díaz Marsá M, Bravo-Ortiz MF, Ibañez A, Baca-García E, Vieta E, Ayuso-Mateos JL, Malpica N, Arango C, Díaz-Caneja CM, Radua J.

    Triangulating the associations of different types of childhood adversity and first-episode psychosis with cortical thickness across brain regions.

    PSYCHOLOGICAL MEDICINE . : 1-14.

    [doi:10.1017/S0033291724002393]

  • Scala M, Sánchez-Reolid D, Sánchez-Reolid R, Fernández-Sotos P, Romero-Ferreiro V, Alvarez-Mon MÁ, Lahera G, Fanelli G, Serretti A, Fabbri C, Fernández-Caballero A, Rodriguez-Jimenez R.

    Differences in emotion recognition between nonimmersive versus immersive virtual reality: preliminary findings in schizophrenia and bipolar disorder.

    International clinical psychopharmacology . : .

    [doi:10.1097/YIC.0000000000000576]

  • Fernández-Fernández R, Ibias J, Del Toro-Pérez C, Lahera G, Gasca-Salas C.

    Alexithymia in Parkinson's Disease: A Meta-analysis.

    The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry . : .

    [doi:10.1016/j.jagp.2024.11.009]

  • Serra-Navarro M, Clougher D, Solé B, Sánchez-Moreno J, González-Pinto A, Jiménez E, Amann BL, Balanzá-Martínez V, Tabarés-Seisdedos R, Arango C, Accardo V, García-Portilla MP, Ibáñez Á, Crespo JM, Ayuso-Mateos JL, Amoretti S, Torrent C, Martínez-Aran A, Vieta E.

    The impact of sex in the effectiveness of functional remediation in bipolar disorder.

    ACTA PSYCHIATRICA SCANDINAVICA . 150(6): 543-561.

    [doi:10.1111/acps.13748]

  • Hernández-Santillán G, Gurpegui M, Alcamí-Pertejo M, Lahera G, Bravo-Ortiz MF.

    Factors associated with depressive symptoms among 1,502 couples in the immediate puerperium.

    INTERNATIONAL JOURNAL OF SOCIAL PSYCHIATRY . : .

    [doi:10.1177/00207640241296047]

  • Varaona A, Molina-Ruiz RM, Gutiérrez-Rojas L, Perez-Páramo M, Lahera G, Donat-Vargas C, Alvarez-Mon MA.

    Snapshot of knowledge and stigma toward mental health disorders and treatment in Spain.

    FRONTIERS IN PSYCHOLOGY . 15: 1372955-1372955.

    [doi:10.3389/fpsyg.2024.1372955]

  • Clougher D, Forte MF, Mezquida G, Sánchez-Torres AM, Serra-Navarro M, Penadés R, Lobo A, Pinto AG, Panadero R, Roldán A, Vieta E, de la Serna E, Trabsa A, Martínez-Aran A, Torrent C, Tortorella A, Menculini G, Ramos-Quiroga JA, Cuesta MJ, Bernardo M, Amoretti S.

    Emotional intelligence and neurocognition profiles in first-episode psychosis: A two-year follow-up study.

    EUROPEAN NEUROPSYCHOPHARMACOLOGY . 85: 66-77.

    [doi:10.1016/j.euroneuro.2024.05.006]

  • León-Quismondo L, Fernández-Liria A, López-Ríos F, Saiz-Ruiz J, García-Montes JM, Ibáñez Á, Stiles BJ, Lahera G.

    Predictors and Moderators of Panic Disorder: Cognitive Behavioral Therapy vs. Acceptance and Commitment Therapy.

    Psicothema . 37(1): 32-41.

    [doi:10.70478/psicothema.2025.37.04]

  • Montes JM, Agüera-Ortiz L, Mané A, Martinez-Raga J, Gutiérrez-Rojas L.

    Clinical decision-making before discharge in hospitalized persons with schizophrenia: a Spanish Delphi expert consensus.

    Frontiers in psychiatry . 15: 1412637-1412637.

    [doi:10.3389/fpsyt.2024.1412637]

  • Llorca-Bofí V, Madero S, Amoretti S, Cuesta MJ, Moreno C, González-Pinto A, Bergé D, Rodriguez-Jimenez R, Roldán A, García-León MÁ, Ibáñez A, Usall J, Contreras F, Mezquida G, García-Rizo C, Berrocoso E, Bernardo M, Bioque M.

    Inflammatory blood cells and ratios at remission for psychosis relapse prediction: A three-year follow-up of a cohort of first episodes of schizophrenia.

    SCHIZOPHRENIA RESEARCH . 267: 24-31.

    [doi:10.1016/j.schres.2024.03.011]

  • Hillers-Rodríguez R, San Vicente-Cano A, Portabales-Barreiro L, Madoz-Gúrpide A.

    Efectos de la pandemia de la COVID-19 en la salud mental de pacientes con psicopatología previa.

    REVISTA ESPANOLA DE SALUD PUBLICA . 98: .